{"id":"NCT00254163","sponsor":"US Oncology Research","briefTitle":"Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients","officialTitle":"A Prospective, Randomized, Open Label, Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-cell Chronic Lymphocytic Leukemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-12","primaryCompletion":"2011-09","completion":"2011-09","firstPosted":"2005-11-15","resultsPosted":"2016-11-03","lastUpdate":"2016-11-03"},"enrollment":184,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["B-Cell Chronic Lymphocytic Leukemia"],"interventions":[{"type":"DRUG","name":"Fludarabine","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"Rituximab","otherNames":[]},{"type":"DRUG","name":"Pentostatin","otherNames":["Nipent"]}],"arms":[{"label":"Fludarabine, Cyclophosphamide, and Rituximab","type":"ACTIVE_COMPARATOR"},{"label":"Pentostatin, Cyclophosphamide, and Rituximab","type":"EXPERIMENTAL"}],"summary":"The purpose of this research study is to find out what effects (good and bad) the combination of Nipent+Cytoxan+Rituxan has on CLL cancer compared to Fludara+Cytoxan+Rituxan. While all of these drugs are approved by the Food and Drug Administration (FDA) for the treatment of other cancers, these combinations are experimental for the treatment of CLL.","primaryOutcome":{"measure":"Infection Rate","timeFrame":"6 cycles of 28-day for FCR and 8 cycles of 21-day for PCR, or until PD, CR, or intolerable toxicity","effectByArm":[{"arm":"FCR Arm","deltaMin":31.4,"sd":null},{"arm":"PCR Arm","deltaMin":36.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":17,"exclusionCount":14},"locations":{"siteCount":11,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":88},"commonTop":["NEUTROPENIA","ASTHENIA","NAUSEA","ANEMIA","LEUKOPENIA"]}}